Management

Hassan Salari, Ph.D.
Chairman & CEO Dr.

Salari is an experienced health care executive with over 20 years of involvement in managing private and publicly traded pharmaceutical companies in North America. Having been the founder and President & CEO of Chemokine Therapeutics from July 1998 to May 2007, Dr. Salari raised over $40 million for the Company, and has made the public listing of the company on the Toronto Stock Exchange as well as Over the Counter Bulletin Board in the United States. Dr. Salari also founded and built the biotechnology company, Inflazyme Pharmaceuticals from 1992 to 1998 and brought the Company public on the Toronto Stock Exchange. His role as President and Chief Executive Officer of Inflazyme Pharmaceuticals included managing its international business affairs. He raised over $30 million for Inflazyme on the public stock market. Dr. Salari was the founding director of Pacgen Biopharma, a publically traded company on the Toronto Stock Exchange Venture Board from December 2006-December 2008. Dr. Salari is also the founder and president of Posh Cosmeceuticals, a specialized cosmetic company with operations in Canada. He is a founding investor and board member of Pacific Therapeutics, a Vancouver based biotechnology company with emphasis in pulmonary diseases. He is the Founder and Chairman of the Board of Neurokine Pharmaceuticals, a Pharmaceutical company in Canada developing new drugs for neurological disease, including Alzheimers diseases.

Previous to his entrepreneurial ventures, Dr. Salari served as consultant and advisor to Merck, Beecham (now "Glaxo"), Rhone Poulenc (now "Sanofi-Avantis"), Upjohn (now "Pfizer"), Beafour-Ipsen (now "Ipsen") and Zymogenetics.

From 1987 to 1998, Dr. Salari was Professor of Medicine at the University of British Columbia. He assembled several research teams in the fields of autoimmunity, inflammation, cardiovascular and cancer. He is the author of over 200 scientific books, journal articles and abstracts and owns over 50 patents. Dr. Salari has Ph.D. in Biochemistry and Microbiology from Southampton University in England.

Audry Lew,
Chief Financial Officer

Mrs Lew is a certified general accountant from the British Columbia Institute of Charter Accounting. She has served for more than 15 years as controller, financial director and financial officer of a number of technology and health care companies. She has experience in both public and private companies accounting practises and GAP.

Dr. David Filer Ph.D.
Director

During the last 10 years, Dr. Filer was self employed and worked as a healthcare analysts in New York. He worked in that capacity for a number of investment bankers and brokerage firms as well as biotechnology companies. In North America. He is a prominent healthcare analyst in New York and assisted companies such as Paramount Biocapital, Sunrise Equities, Centercort Capital, Spencer Trask Ventures, Altira Capital, Cornerstone Pharmaceuticals, Cleveland Biolabs, Advaxis, Biocancell, United Therapeutics, Enzon Inc. Working with investors professional managers and inventors to establish and guide their companies seeking the clinical investigation and commercial development of cutting edge technologies and products. Furthermore he managed the merger of Unigene and Pfizer in deal valued at $60 MM. Dr. Filer has a Ph.D. in Microbiology and Molecular Biology and worked at the New York University Medical Center as teaching instructor from 1984-1999.

Mr. Christian Bezy, B.Sc.
Director

Mr. Bezy is a businessman with extensive experience in resource sector. He has over 30 years experience in the mining industry, managing a large number of employees in several million dollar companies. He has experience in discovery of vast land based gold and iron mines. He has worked for several resource companies in Canada, including Kiena, Sigma, East-Amphi, Abcourt, Dorval, Mt-Laurier, and Mt-Wright at Fermont, and Samira in West Africa. He obtained his B.Sc. in Geology from the University of Quebec in Montreal in 1978. Mr. Bezy brings wealth of knowledge and experience to the Company’s managerial and financial matters.